ReviewJournal of pain research2021
Telemedicine Applications for the Evaluation of Patients with Non-Acute Headache: A Narrative Review.
Review in Journal of pain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 28 citations in OpenAlex.
- Engagement and predictors of use of a smartphone app for migraine self-management: A secondary analysis of the EMMA trial.Headache · 2026Trial
- Telemedicine for headache disorders in real-world practice: from patient experience to health system impact.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- Evaluating migraine tracking methods: a study of headache diary use in Lithuania.Frontiers in neurology · 2026Article
- Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review.Journal of clinical medicine · 2025Review
- Telemedicine interventions in type 2 diabetes management: a protocol for systematic review and network meta-analysis.BMJ open · 2024Article
- The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.The journal of headache and pain · 2024Review
- Twenty-Five Years of AI in Neurology: The Journey of Predictive Medicine and Biological Breakthroughs.JMIR neurotechnology · 2024Article
- Virtual neurology survey: Factors influencing virtual care use among Ontario neurologists.SAGE open medicine · 2024Article
- The Calm after the Storm: A State-of-the-Art Review about Recommendations Put Forward during the COVID-19 Pandemic to Improve Chronic Pain Management.Journal of clinical medicine · 2023Review
- Telemedicine in Headache Medicine: A Narrative Review.Current pain and headache reports · 2023Review
- A Novel Virtual-Based Comprehensive Clinical Approach to Headache Care.Journal of clinical medicine · 2023Article
- Headache providers' perspectives of headache diaries in the era of increasing technology use: a qualitative study.Frontiers in neurology · 2023Article
- Virtual Access to Subspecialty Care.Primary care · 2022Review
- Role of Estrogens in Menstrual Migraine.Cells · 2022Review
- Video consultation for non-acute headache by neurologist is not inferior to traditional consultations in terms of headache consultation rate at follow-up:Frontiers in neurologyArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has spurred a hasty transition to virtual care but also an abundance of new literature highlighting telehealth's capabilities and limitations for various healthcare applications. In this review, we aim to narrate the current state of the literature on telehealth applied to migraine care. First, telemedicine in the context of non-acute headache management has been shown to produce non-inferior patient outcomes when compared to traditional face-to-face appointments. The assignment of patients to telehealth appointments should be made after referring more urgent cases to dedicated in-person clinics. During the virtual appointment, physicians can ask their patients about the "3 F's" in order to perform a thorough assessment of their headaches: frequency of headache days, frequency of acute medication usage and functional impairment. Clinical assessment scores that have been studied and deemed feasible for telemedicine, safe and efficient include the HIT-6, VAS and MIDAS scores. Although MIDAS was found to be redundant and inadequate to use on a daily basis, we suggest that it can be useful in periodic remote follow-up appointments. Additionally, several mobile health apps have been studied including Migraine Buddy, Migraine Coach and Migraine Monitor. All of these are appropriate for use in telemedicine when combined with an adequate trial period with Migraine Buddy being rated the highest, as it captures the most detailed clinical picture. High satisfaction rates have been reported for virtual headache management which were shown to be equal to in-person consults. These are based on patients' perceived increase in convenience due to avoided travel time, less disruption of their daily routine and feeling more comfortable in the environment of their choice. Despite this, limitations such as technological knowledge, access to videoconferencing modalities and having a more impersonal consultation with the physician may hinder some patients from adopting this service.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.